ALXO · Alx Oncology Holdings Inc
$1.96
+0.02 (+1.03%)
At close · Aug 14
Market Cap
$271.02M
Shares
138.28M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$0
FY2022
Net Income
-$101.7M
+24.6%
FY2025
Operating Margin
-3693.99%
-3294pp
FY2020
Diluted EPS
-$1.90
+26.4%
FY2025
Operating Cash Flow
-$84.14M
+31%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | $0 | $0 | $1.18M | $4.8M | $2.07M | |
| $61.83M | $77M | $116.37M | $141.8M | $98.4M | $60.17M | $28.96M | $16.31M | $11.27M | |
| $20.96M | $23.85M | $26.09M | $28.48M | $29.04M | $23.39M | $14.81M | $3.31M | $2.6M | |
| $545K | $706K | $872K | $836K | $342K | $51K | $202K | $429K | $431K | |
| $82.55M | $104.02M | $142.47M | $170.28M | $127.44M | $83.56M | $44.85M | $23.98M | $15.75M | |
| -$82.55M | -$104.02M | -$142.47M | -$170.28M | -$127.44M | -$83.56M | -$43.66M | -$19.18M | -$13.68M | |
| — | — | — | — | — | — | -3693.99% | -399.98% | -662.02% | |
| -$82.01M | -$103.32M | -$141.6M | -$169.44M | -$127.09M | -$83.5M | -$43.46M | -$18.75M | -$13.25M | |
| $1.41M | $1.6M | $1.73M | $1.57M | $238K | $13K | — | — | — | |
| $4.07M | $3.96M | $9.37M | $10.65M | $4.28M | $91K | — | — | — | |
| -$92K | -$36K | -$20K | $389K | -$22K | -$7000 | -$1.34M | -$5000 | — | |
| — | -$101.7M | -$134.85M | -$160.81M | -$123.42M | -$83.48M | -$45.5M | -$19.21M | -$13.69M | |
| — | $0 | $0 | $0 | $64K | -$21K | $241K | $34K | $45K | |
| -$80.89M | -$101.7M | -$134.85M | -$160.81M | -$123.48M | -$83.46M | -$45.74M | -$19.24M | -$13.73M | |
| — | — | — | — | — | — | -3869.71% | -401.23% | -664.3% | |
| — | — | — | — | -$123.48M | -$83.46M | -$50.94M | -$23.27M | -$17.4M | |
| -$81.15M | -$101.94M | -$134.83M | -$159.7M | -$124.33M | -$83.46M | -$50.94M | — | — | |
| USD/shares | — | -$1.90 | -$2.58 | -$3.74 | -$3.03 | -$2.07 | -$2.76 | — | — |
| USD/shares | — | -$1.90 | -$2.58 | -$3.74 | -$3.03 | -$2.07 | -$2.76 | — | — |
| shares | — | 53.66M | 52.17M | 42.99M | 40.7M | 40.31M | 18.49M | 3.08M | 2.75M |
| shares | — | 53.66M | 52.17M | 42.99M | 40.7M | 40.31M | 18.49M | 3.08M | 2.75M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 4.35×
EV/EBIT
—
Peer median 9.33×
P/E (TTM)
—
Peer median 10.64×
Peer medians compare against the 321 similar-size Biotechnology companies (of 545 listed).
Key facts
CIK
1810182
CUSIP
00166B105
13F (30d)
95 filings
94 filers
Visit website
Investor relations